Anastomosis Device Market Summary
- The anastomosis device market size is expected to expand at a compound annual growth rate (CAGR) of 5.3% between 2025 and 2032.
- The anastomosis device market is experiencing strong growth, driven by the rising incidence of colorectal cancer and coronary artery disease (CAD), increasing surgical volumes, and supportive regulatory approvals, all of which are contributing to overall market expansion.
Key Anastomosis Device Market Trends & Insights
- The leading Anastomosis Device Companies operating in the market include - B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.
- North America is expected to account for a substantial share of the anastomosis device market, driven by rising colorectal cancer incidence, the strong presence of leading market players, and ongoing product innovations supported by favorable regulatory approvals.
- Surgical staplers enable rapid application, reduced tissue response, lower infection risk, and secure wound closure for patients undergoing cardiovascular and gastrointestinal surgeries. They are available in multiple shapes and sizes, making surgical closure more efficient and adaptable to different procedural needs.
- According to the British Heart Foundation’s Global Heart & Circulatory Diseases Factsheet (2024), approximately 200 million people worldwide are living with coronary artery disease (CAD). Anastomosis devices improve accuracy and procedural efficiency in surgeries such as coronary artery bypass grafting (CABG), helping enhance patient outcomes and lower complication rates, which is driving their growing role in CAD treatment.
Request for unlocking the CAGR of the Anastomosis Device Market Insights
Factors Contributing to the Rise in Growth of the Anastomosis Device Market
- Rising Prevalence of Conditions Requiring Anastomosis Procedures: The increasing incidence of gastrointestinal disorders, cardiovascular diseases, colorectal cancer, and bariatric surgeries is driving demand for anastomosis devices, as these procedures frequently require safe and efficient tissue connection.
- Growing Adoption of Anastomosis Devices in Minimally Invasive Surgeries: Surgeons are increasingly adopting anastomosis devices due to their ability to reduce operative time, improve surgical precision, minimize leakage risk, and support the shift toward laparoscopic and robotic-assisted surgeries.
- Anastomosis Device Technological Advancements & Product Launches: Continuous innovation, including circular staplers, compression anastomosis devices, bioabsorbable materials, and smart surgical instruments, along with frequent product launches, is enhancing clinical outcomes and expanding the device portfolio.
- Government Awareness Initiatives for Anastomosis Devices: Government-led programs promoting early diagnosis, advanced surgical care, and improved access to modern medical devices are supporting higher adoption of anastomosis devices across public healthcare systems.
- Expanding Access in Emerging Markets: Improving healthcare infrastructure, rising healthcare expenditure, medical tourism growth, and increasing availability of advanced surgical technologies in emerging economies are accelerating the penetration of anastomosis devices globally.
Anastomosis Device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2032 owing to the increasing instances of chronic disorders and the rising product developmental activities worldwide
The Anastomosis Device Market is projected to grow at a 5.3% CAGR during the forecast period from 2025 to 2032. The Anastomosis Device Market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease (CAD) among the population, clearances from regulatory bodies, and the growing burden of surgeries are factors that are expected to escalate the overall growth of the Anastomosis Device Market during the forecast period from 2025 to 2032.
What are the latest Anastomosis Device Market Dynamics and Trends?
Data from the Global Cancer Observatory 2024, stated that in the year 2022 there were about 1926425 total colorectum cancer cases worldwide. The same source further stated that Asia accounted for 966399 colorectum cancer cases, comprising almost 50% of the total cases, and Europe accounted for 538262 colorectum cancer cases. The high incidence of colorectal cancer globally drives the demand for surgical treatments, where Anastomosis Device play a critical role in resecting and reconnecting the colon. These devices enhance surgical precision, reduce complications, and improve patient outcomes, making them indispensable in colorectal cancer surgeries and expanding their Market presence.
According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world. Anastomosis Device enhance precision and efficiency in procedures like coronary artery bypass grafting (CABG), improving patient outcomes and reducing complications, making them increasingly integral to CAD Treatment.
Increased product development activities by regulatory bodies are also slated to witness Market growth for Anastomosis Device. For example, in January 2023, Lydus Medical announced that its Vesseal microvascular anastomosis suture deployment system received 510(k) clearance from the US Food and Drug Administration (FDA). Hence, the interplay of all the above-mentioned factors are expected to drive the Market for Anastomosis Device Market during the given forecast period from 2025 to 2032.
However, complications due to anastomosis, and the increasing demand for minimally invasive or non-invasive treatment approach, among others may restrict the Market growth of Anastomosis Device.
Anastomosis Device Market Report Segmentation
Anastomosis Device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). In the product segment of the Anastomosis Device Market, the surgical staplers category is expected to have a significant revenue share in the year 2023. This is primarily owing to the rising focus of manufacturers toward developing technologically advanced surgical staplers for an improved and efficient connection of vessels and the other various advantages offered by the category.
The surgical staplers provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The staplers are also available in different shapes and sizes, easing the process of closure during surgery. Further, the increasing product launches and regulatory approvals of the Anastomosis Device will aid in increasing its demand in the Market. For instance, in March 2021, the FDA approved Viola clamps, a less proximal anastomosis device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).
Therefore, owing to the aforementioned factors, the surgical staplers category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomosis device Market during the forecast period.
Anastomosis Device Market Segmentation
Anastomosis Device Market by Product
- Surgical Staplers
- Surgical Sutures
- Surgical Sealants
- Surgical Adhesives
Anastomosis Device Market by Usability
- Disposable
- Reusable
Anastomosis Device Market by Application
- Cardiovascular Surgery
- Gastrointestinal Surgery, and Others
Anastomosis Device Market by End-User
- Hospitals & Clinics
- Ambulatory Surgical Centers, and Others
Anastomosis Device Market by Geography
- North America Anastomosis Device Market
- United States Anastomosis Device Market
- Canada Anastomosis Device Market
- Mexico Anastomosis Device Market
- Europe Anastomosis Device Market
- France Anastomosis Device Market
- Germany Anastomosis Device Market
- United Kingdom Anastomosis Device Market
- Italy Anastomosis Device Market
- Spain Anastomosis Device Market
- Russia Anastomosis Device Market
- Rest of Europe
- Asia-Pacific Anastomosis Device Market
- China Anastomosis Device Market
- Japan Anastomosis Device Market
- India Anastomosis Device Market
- Australia Anastomosis Device Market
- South Korea Anastomosis Device Market
- Rest of Asia Pacific
- Rest of the World (RoW)
- Middle East Anastomosis Device Market
- Africa Anastomosis Device Market
- South America Anastomosis Device Market
Anastomosis Device Regional Insights
Anastomosis Device is expected to witness the fastest growth in the overall Myopia Medical Devices Market
Among all the regions, North America is estimated to hold a significant revenue share in the Anastomosis Device Market. This can be attributed to several factors such as rising colorectum cancer cases, the presence of key Market players, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the Anastomosis Device Market in the North America region during the forecast period from 2025 to 2032.
According to data from the Global Cancer Observatory 2024, it stated that in the year 2022, there were 183911 total colorectum cancer cases in the region. The same source further stated that the US accounted for 160186 colorectum cancer cases which is almost 87% of the total cases, and Canada accounted for 23725 colorectum cancer cases. Anastomosis Device are essential for reconnecting bowel segments during surgical resections. Advanced devices improve surgical precision, reduce complications, and enhance recovery, making them indispensable in managing colorectal cancer cases and expanding their Market.
Additionally, in October 2024, GT Metabolic Solutions Inc., a global leader in magnetic compression anastomosis surgery, announced that the U.S. Food and Drug Administration cleared GT Metabolic's MagDI™ System for side-to-side duodeno-ileal (DI) anastomosis.
The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional Anastomosis Device Market growth. The presence of key players such as Johnson & Johnson Services, Inc., B.Braun Melsungen AG, Medtronic with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the Market, and supportive reimbursement programs providing immense growth opportunities for the same.
Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the Anastomosis Device Market during the forecast period from 2025 to 2032.
|
Report Metrics |
Details |
|
Study Period |
2022 to 2032 |
|
Forecast Period |
2025-2032 |
|
CAGR |
5.3% (Request Sample To Know More) |
|
Anastomosis Device Market |
USD XX million by 2032 |
|
Key Anastomosis Devices Companies |
B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others |
Key Anastomosis Device Companies in the Market Landscape:
The leading Anastomosis Device operating in the market inlcude -
- B. Braun Melsungen AG
- Intuitive Surgical
- BAXTER
- CryoLife Inc
- Johnson & Johnson Services Inc
- Medtronic
- Sinolinks Medical Innovation Inc
- microcuremed
- BIOWIN PHARMACEUTICAL CO. LIMITED
- Waston Medical Corporation
- W. L. Gore & Associates Inc
- Hangzhou Demo Medical Technology Co. Ltd
- BD
- Dolphin Sutures
- GPC medical
- Golden Stapler Surgical Co. Ltd
- JIANGSU JOYMED TECH CO. LTD
- Changzhou Haiers Medical Devices Co. Ltd
- Shanghai MedEco Industry Co. Ltd
- ChangZhou WeiPu Medical Devices CO. LTD, and others
Recent Developmental Activities in the Anastomosis Device Market
- In March 2025, GT Metabolic Solutions, a company specializing in magnetic surgery, earned U.S. Food and Drug Administration (FDA) clearance for a larger, 50 mm MagDI magnet to complement the system’s current 40 mm magnet. The expansion allows surgeons to accommodate a wider range of patients in magnet-assisted surgery for duodenal-ilial anastomosis. The MagDI system is currently the only FDA-cleared, commercially available product for magnetic compression anastomosis.
- In April 2021, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.
- In March 2021, Johnson & Johnson launched the ECHELON Stapler, which is a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.
- In February 2021, Vascular Graft Solutions Ltd. received a receipt of Marketing authorization from the FDA for VIOLA. This is a new device for clampless proximal anastomosis in CABG.
Key Anastomosis Device Highlights Summary (2022–2025)
| Category | Key Developments (2022–2025) |
|---|---|
| Product Launches | Introduction of next-generation circular staplers, compression anastomosis devices, and minimally invasive surgical systems designed to reduce leakage risk, operative time, and post-operative complications. |
| Regulatory Approvals | Multiple anastomosis devices received FDA clearance and CE marking, particularly for colorectal, gastrointestinal, and cardiovascular surgeries, supporting wider clinical adoption across key markets. |
| Partnerships | Strategic collaborations between medical device manufacturers and hospitals, robotic surgery platforms, and regional distributors to accelerate innovation, clinical validation, and global market penetration. |
| Acquisitions | Leading medtech companies acquired niche surgical device firms to strengthen anastomosis portfolios, expand proprietary technologies, and enhance presence in high-growth surgical segments. |
| Company Strategy | Focus on minimally invasive and robotic-assisted surgery compatibility, portfolio diversification, geographic expansion into emerging markets, and |
Impact Analysis
AI Advancement in Anastomosis Device
- AI-Driven Surgical Precision: Artificial intelligence is enhancing anastomosis device accuracy by assisting surgeons with real-time tissue assessment, optimal placement guidance, and alignment optimization, reducing the risk of leaks and post-operative complications.
- Smart Anastomosis Devices with Real-Time Feedback: AI-enabled anastomosis devices integrate sensors and analytics to provide real-time feedback on tissue thickness, perfusion, and compression force, helping surgeons make data-driven intraoperative decisions.
- Predictive Analytics for Complication Prevention: Machine learning algorithms analyze patient data, surgical parameters, and historical outcomes to predict anastomotic failure risk, enabling personalized device selection and procedural planning.
- Integration with Robotic-Assisted Surgery Platforms: AI advancements support seamless integration of anastomosis devices with robotic surgical systems, improving dexterity, consistency, and precision in minimally invasive and complex procedures.
- Enhanced Training and Surgical Simulation: AI-powered simulation tools and virtual reality platforms are being used to train surgeons on anastomosis techniques, improving proficiency, reducing learning curves, and standardizing procedural outcomes.
- Automated Quality Control and Post-Operative Monitoring: AI systems assist in post-surgical monitoring by analyzing imaging and clinical data to detect early signs of anastomotic leaks or healing issues, enabling timely intervention.
- Continuous Device Optimization through Data Learning
Data collected from AI-enabled anastomosis devices is used to continuously refine device design, algorithms, and performance, driving iterative innovation and improved long-term clinical outcomes.
Tariff Inclusion in Anastomosis Device
- Understanding Tariff Inclusion in Anastomosis Devices: Tariff inclusion analysis evaluates how import and export duties, customs regulations, and trade policies impact the pricing, sourcing, and commercialization of anastomosis devices across regions, helping stakeholders anticipate cost fluctuations.
- Cost Management: By identifying applicable tariffs and duty structures, manufacturers and distributors can accurately estimate landed costs, optimize pricing strategies, and protect margins while remaining competitive in both mature and emerging markets.
- Supply Chain Optimization: Tariff analysis enables companies to redesign supply chains by selecting favorable manufacturing locations, diversifying suppliers, and leveraging free trade agreements to reduce tariff exposure and ensure uninterrupted device availability.
- Regulatory Navigation: Insights into regional trade and tariff frameworks help clients align product classification, documentation, and compliance strategies, minimizing customs delays and reducing the risk of penalties during cross-border shipments.
- Strategic Planning: Understanding tariff implications supports long-term strategic decisions such as market entry prioritization, localization of production, partnership selection, and investment planning, enabling sustainable growth in the anastomosis device market.
Startup Funding & Investment Trends in Anastomosis Device
| Company Name | Total Funding | Main Products/Focus | Stages of Development | Core Technology |
|---|---|---|---|---|
| Lydus Medical | ~$2.7M seed / Pre-A funding | Vesseal automated microvascular anastomosis device | Early clinical development; preparing for regulatory clearance | Automated microsurgical anastomosis (precision vessel connection) |
| NiTi Surgical Solutions | ~$18.5M Series F financing | ColonRing™ and BioDynamix™ Anastomosis Technology | Market launch & product rollout | Shape-memory nitinol internal tissue closure |
| Plio Surgical | ~€2.5M grant & early-stage funding | Magnetic anastomosis implant with micro-sensors | Early R&D and prototype development | Smart magnetic compression implant & leak detection (grant supported) |
| GI Windows Surgical | ~$37M funding reported | Flexagon magnetic anastomosis device | Advanced clinical development | Self-forming magnet anastomosis technology |
| (Emerging Robotics Developer) Deep Surgery* | Series A funding secured* | FUNZAR Microsurgical Robot (includes vascular anastomosis capabilities) | Clinical validation & global expansion | AI-focused microsurgical robotics (clinical phase) |
Key Takeaways from the Anastomosis Device Market Report Study
- Market size analysis for current Anastomosis Device Market size (2023), and Market forecast for 6 years (2025 to 2032)
- Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
- Key Anastomosis Device Companies dominating the Global Market
- Various opportunities available for other competitors in the Anastomosis Device Market space
- What are the top-performing segments in 2023? How these segments will perform in 2032?
- Which are the top-performing regions and countries in the current Anastomosis Device Market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Anastomosis Device Market growth in the coming future?
Target Audience who can be benefited from this Anastomosis Device Market Report Study
- Anastomosis device providers
- Research organizations and consulting Anastomosis Device Companies
- Anastomosis Device-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in Anastomosis Device
- Various end-users who want to know more about the Anastomosis Device Market and the latest developments in the Anastomosis Device Market
Stay updated with us for Recent Articles @ Latest DelveInsight Blogs
